X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (52) 52
index medicus (41) 41
female (32) 32
oncology (29) 29
human necessities (28) 28
hygiene (28) 28
medical or veterinary science (28) 28
preparations for medical, dental, or toilet purposes (28) 28
chemistry (27) 27
metallurgy (27) 27
organic chemistry (27) 27
male (26) 26
specific therapeutic activity of chemical compounds ormedicinal preparations (26) 26
heterocyclic compounds (24) 24
middle aged (23) 23
prognosis (20) 20
adult (19) 19
animals (18) 18
cancer (18) 18
pathology (18) 18
aged (14) 14
breast cancer (14) 14
cell line, tumor (14) 14
metastasis (14) 14
analysis (13) 13
immunohistochemistry (13) 13
mice (13) 13
breast neoplasms - pathology (10) 10
mice, scid (10) 10
research (10) 10
retrospective studies (9) 9
surgery (9) 9
apoptosis - drug effects (8) 8
cancer research (8) 8
disease-free survival (8) 8
expression (8) 8
growth (8) 8
aged, 80 and over (7) 7
apoptosis (7) 7
biomedicine (7) 7
biomedicine general (7) 7
cell biology (7) 7
cell proliferation (7) 7
chemotherapy (7) 7
immunology (7) 7
in-vitro (7) 7
lung neoplasms - metabolism (7) 7
lung neoplasms - pathology (7) 7
oncology, experimental (7) 7
survival (7) 7
adolescent (6) 6
biomarkers, tumor - analysis (6) 6
biomarkers, tumor - genetics (6) 6
cell movement - drug effects (6) 6
cell proliferation - drug effects (6) 6
health aspects (6) 6
kaplan-meier estimate (6) 6
medical prognosis (6) 6
melanoma - pathology (6) 6
tumors (6) 6
xenograft model antitumor assays (6) 6
angiogenesis (5) 5
antineoplastic agents - pharmacology (5) 5
breast neoplasms - mortality (5) 5
carcinoma (5) 5
care and treatment (5) 5
cell migration (5) 5
development and progression (5) 5
follow-up studies (5) 5
hungary (5) 5
lung-cancer (5) 5
medicine & public health (5) 5
melanoma (5) 5
melanoma - drug therapy (5) 5
melanoma - metabolism (5) 5
mutation (5) 5
risk factors (5) 5
biomarkers, tumor - metabolism (4) 4
breast (4) 4
cancer patients (4) 4
carcinoma, non-small-cell lung - metabolism (4) 4
case-control studies (4) 4
child (4) 4
diagnosis (4) 4
enzyme inhibitors - pharmacology (4) 4
gene expression (4) 4
gene expression regulation, neoplastic (4) 4
hematology, oncology and palliative medicine (4) 4
hungary politics and government (4) 4
hypoxia (4) 4
lung neoplasms - genetics (4) 4
lymphatic metastasis (4) 4
medical research (4) 4
neovascularization, pathologic - pathology (4) 4
proteins (4) 4
radiotherapy (4) 4
receptor, erbb-2 - analysis (4) 4
receptors, estrogen - analysis (4) 4
signal transduction - drug effects (4) 4
squamous cell carcinoma (4) 4
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (95) 95
Hungarian (28) 28
German (7) 7
French (4) 4
Norwegian (3) 3
Danish (2) 2
Finnish (2) 2
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CLINICAL EPIDEMIOLOGY, ISSN 1179-1349, 2018, Volume 10, pp. 1865 - 1866
István KenesseyNational Cancer Registry of Hungary, National Institute of Oncology, Budapest, HungaryI would like to thank Menyhárt et al1 for their recent... 
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | Medical advice systems | Analysis | Mortality | Reports | Health aspects | Statistics | Ethical aspects | Cancer
Journal Article
Journal of Clinical Pathology, ISSN 0021-9746, 04/2015, Volume 68, Issue 4, pp. 274 - 282
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 06/2019, Volume 285, pp. 47 - 52
Dilated cardiomyopathy (DCM) incidence during and after anthracycline therapy is highly dependent on anthracycline cumulative dose (CD), but its detailed risk... 
Heart failure | Anthracycline | Cardiomyopathy | Risk-prediction score | CARDIAC & CARDIOVASCULAR SYSTEMS | HFE GENE | DOXORUBICIN | TOXICITY | PREVALENCE | CAPECITABINE | 5-FLUOROURACIL | INDUCED CARDIOTOXICITY | MUTATIONS | LEADING CAUSES | HEMOCHROMATOSIS | Anthracyclines | Chemotherapy | Breast cancer | Models | Coronary heart disease | Risk factors | Cancer
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2015, Volume 10, Issue 2, p. e0117021
While targeted therapy brought a new era in the treatment of BRAF mutant melanoma, therapeutic options for non-BRAF mutant cases are still limited. In order to... 
ZOLEDRONIC ACID | CANCER-CELLS | METASTATIC MELANOMA | POTENT INHIBITOR | IN-VITRO | SIGNALING PATHWAYS | N-RAS | INDUCED APOPTOSIS | MULTIDISCIPLINARY SCIENCES | BISPHOSPHONATE PAMIDRONATE | GENETIC ALTERATIONS | PTEN Phosphohydrolase - genetics | Prenylation - drug effects | Apoptosis - drug effects | Cell Survival | Membrane Proteins - genetics | Humans | Male | Zoledronic Acid | Melanoma - pathology | Mice, SCID | Animals | GTP Phosphohydrolases - genetics | Melanoma - genetics | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Cell Line, Tumor | Diphosphonates - therapeutic use | Mice | Imidazoles - therapeutic use | Mutation | Biochemistry | Health aspects | Melanoma | Apoptosis | Cell proliferation | Biotechnology | Animal models | Thoracic surgery | Liver | Xenotransplantation | Colorectal cancer | Raf protein | Cytotoxicity | Oncology | Activation | Metastasis | Kinases | Synergism | Cancer therapies | Anticancer properties | Proteins | Cell growth | Surgery | Xenografts | Cell cycle | Zoledronic acid | Inhibition | Spleen | Medical research | Enzymes | Poly(ADP-ribose) polymerase | Pharmacology | Breast cancer | Ribosomal protein S6 | Cisplatin | Pathology | Sensitivity | Acids | Hepatocytes | Cell death | Cell lines | Antitumor activity | Viability | Prostate | Colonization | Cell migration | PTEN protein
Journal Article
Helicobacter, ISSN 1083-4389, 08/2017, Volume 22, Issue 4, p. n/a
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2013, Volume 8, Issue 10, p. e77459
Recombinant human erythropoietins (rHuEPOs) are used to treat cancer-related anemia. Recent preclinical studies and clinical trials, however, have raised... 
SURVIVAL | STIMULATING AGENTS | IN-VITRO | IMPACT | RECOMBINANT-HUMAN-ERYTHROPOIETIN | MULTIDISCIPLINARY SCIENCES | GROWTH | TUMOR-CELLS | XENOGRAFT | HYPOXIA | CANCER | Multivariate Analysis | Adenocarcinoma - pathology | Prognosis | Adenocarcinoma of Lung | Humans | Middle Aged | Deoxycytidine - pharmacology | Lung Neoplasms - pathology | Male | Receptors, Erythropoietin - genetics | Biomarkers, Tumor - metabolism | Female | Adenocarcinoma - genetics | Gene Expression Regulation, Neoplastic - drug effects | Bronchoscopy | Lung Neoplasms - genetics | Recombinant Proteins - pharmacology | Mice, SCID | Xenograft Model Antitumor Assays | Animals | Cell Line, Tumor | Biomarkers, Tumor - genetics | Cell Proliferation - drug effects | Mice | Receptors, Erythropoietin - metabolism | Deoxycytidine - analogs & derivatives | Adenocarcinoma | Chemotherapy | RNA | Erythropoietin | Oncology, Experimental | Research | Lung cancer, Non-small cell | Cancer | Cell proliferation | Drugs | Biotechnology | Thoracic surgery | Gemcitabine | Xenotransplantation | Lung cancer | Clinical trials | Oncology | Biology | mRNA | Malignancy | Metastasis | Cancer therapies | Angiogenesis | Cell growth | Surgery | Xenografts | Recombinant | Medical research | Immunoglobulins | Internal medicine | Anemia | Non-small cell lung carcinoma | Patients | Endothelial cells | Studies | Polymerase chain reaction | Pathology | Medical prognosis | Cell lines | Uridine | Hypoxia | In vivo methods and tests | Tumors | Apoptosis | Medical Engineering | Engineering and Technology | Medicinteknik | Teknik
Journal Article